This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Johnson's Monday Lab Sandbox for Insulin Receptor
From Proteopedia
(Difference between revisions)
| Line 13: | Line 13: | ||
===How Insulin Binds=== | ===How Insulin Binds=== | ||
| - | The insulin receptor unit has four separate sites for the insulin molecule to bind to. There are two pairs of two identical binding sites referred to as 1 and 1' and then 2 and 2'. The insulin molecules bind to these sites mostly through [http://en.wikipedia.org/wiki/Hydrophobic_effect hydrophobic interactions]. Despite a majority of the interactions being similar, sites 1 and 1' have a higher binding affinity than sites 2 and 2' due to site one having a larger surface area (706 square angstroms) exposed for insulin to bind to compared to site 2 (394 square angstroms)<ref name="Uchikawa">. | + | The insulin receptor unit has four separate sites for the insulin molecule to bind to. There are two pairs of two identical binding sites referred to as 1 and 1' and then 2 and 2'. The insulin molecules bind to these sites mostly through [http://en.wikipedia.org/wiki/Hydrophobic_effect hydrophobic interactions]. Despite a majority of the interactions being similar, sites 1 and 1' have a higher binding affinity than sites 2 and 2' due to site one having a larger surface area (706 square angstroms) exposed for insulin to bind to compared to site 2 (394 square angstroms)<ref name="Uchikawa">. It was found that at least three insulin molecules would have to bound to the receptor for the receptor to take on its active “T-state” conformation <ref name=”Uchikawa”>. The difference between have the fully bound state with four insulins and the three insulin bound state is minimal compared to the difference between two and three insulins bound <ref name=”Uchikawa”>. |
| - | + | ||
| - | It was found that at least three insulin molecules would have to bound to the receptor for the receptor to take on its active “T-state” conformation <ref name=”Uchikawa”>. The difference between have the fully bound state with four insulins and the three insulin bound state is minimal compared to the difference between two and three insulins bound <ref name=”Uchikawa”>. | + | |
Revision as of 22:57, 21 March 2020
Your Heading Here (maybe something like 'Structure')
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ 3.0 3.1 . It was found that at least three insulin molecules would have to bound to the receptor for the receptor to take on its active “T-state” conformation <ref>. The difference between have the fully bound state with four insulins and the three insulin bound state is minimal compared to the difference between two and three insulins bound <ref name=”Uchikawa”>. [http://</li> <li id="cite_note-Boucher-3">[[#cite_ref-Boucher_3-0|↑]] Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014 Jan 1;6(1). pii: 6/1/a009191. doi:, 10.1101/cshperspect.a009191. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/24384568 24384568] doi:[http://dx.doi.org/10.1101/cshperspect.a009191 http://dx.doi.org/10.1101/cshperspect.a009191]</li> <li id="cite_note-Meyts-4">[[#cite_ref-Meyts_4-0|↑]] De Meyts P. The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia. 1994 Sep;37 Suppl 2:S135-48. doi: 10.1007/bf00400837. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/7821729 7821729] doi:[http://dx.doi.org/10.1007/bf00400837 http://dx.doi.org/10.1007/bf00400837]</li></ol></ref>
Student Contributors
- Maxwell Todd
- Abby Hillan
- Andrew Scheel
